- Home
- ELTX vs MPU Comparison
ELTX vs MPU Comparison
Compare ELTX & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- MPU
- Stock Information
- Founded
- ELTX 2011
- MPU 1989
- Country
- ELTX United States
- MPU Singapore
- Employees
- ELTX N/A
- MPU N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- MPU Transportation Services
- Sector
- ELTX Health Care
- MPU Consumer Discretionary
- Exchange
- ELTX Nasdaq
- MPU Nasdaq
- Market Cap
- ELTX 121.7M
- MPU 35.5M
- IPO Year
- ELTX N/A
- MPU 1998
- Fundamental
- Price
- ELTX $7.91
- MPU $1.63
- Analyst Decision
- ELTX Strong Buy
- MPU
- Analyst Count
- ELTX 2
- MPU 0
- Target Price
- ELTX $9.50
- MPU N/A
- AVG Volume (30 Days)
- ELTX 49.0K
- MPU 673.0K
- Earning Date
- ELTX 08-12-2025
- MPU 08-13-2025
- Dividend Yield
- ELTX N/A
- MPU N/A
- EPS Growth
- ELTX N/A
- MPU N/A
- EPS
- ELTX N/A
- MPU N/A
- Revenue
- ELTX N/A
- MPU $35,228,600.00
- Revenue This Year
- ELTX N/A
- MPU N/A
- Revenue Next Year
- ELTX N/A
- MPU N/A
- P/E Ratio
- ELTX N/A
- MPU N/A
- Revenue Growth
- ELTX N/A
- MPU 305.32
- 52 Week Low
- ELTX $3.35
- MPU $0.49
- 52 Week High
- ELTX $9.99
- MPU $1.98
- Technical
- Relative Strength Index (RSI)
- ELTX 59.19
- MPU 77.55
- Support Level
- ELTX $7.57
- MPU $0.80
- Resistance Level
- ELTX $8.09
- MPU $1.70
- Average True Range (ATR)
- ELTX 0.31
- MPU 0.19
- MACD
- ELTX -0.10
- MPU 0.08
- Stochastic Oscillator
- ELTX 53.03
- MPU 89.22
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.